Story perspectives
DEA Temporarily Schedules Synthetic Kratom Extracts as Schedule I
By Drooid · · How we work
1 of 1
Story summary
- DEA announced temporary Schedule I classification for synthetic kratom extracts.
- HHS backed the proposal and set concentration thresholds for the targeted compounds.
- The rule targets 7-hydroxymitragynine, mitragynine pseudoindoxyl, MGM-15, and MGM-16, excluding natural kratom.
- Clinical professor Oliver Grundmann said extracts lack accepted medical use, justifying Schedule I status.
- Two University of Mississippi students were found near synthetic blends, raising safety concerns.